of reports on the findings of NAP6, the latest Royal College of Anaesthetists National Audit Project which focused on identification and treatment of perioperative anaphylaxis. This was an enormous project involving every eligible NHS hospital; it comprised a protocol and methods paper, 3 national survey of anaesthetists' experiences and perceptions, 4 a national survey of allergy clinics, 5 a national survey of anaesthetic workload, 6 a year-long registry and analysis of all significant cases of perioperative anaphylaxis, 7, 8 and a national survey of perioperative allergen exposure. 9 The team are to be congratulated for this impressive work. In a review of 266 patients, they estimate an incidence of anaphylaxis of at least 1 in every 10 000 anaesthetics in the UK due most frequently to administration of antibiotics, neuromuscular blocking agents, chlorhexidine, or patent blue dye. If previous National Audit Projects (NAPs) are any guide, we can expect a lasting positive impact on patient care worldwide. 10 In the face of such success, it may seem unreasonable to ask if there is anything to learn from NAP6 about the conduct and reporting of future projects. Nevertheless, the continued success of NAPs relies on a constructive but critical appraisal. The NAPs continue a long tradition of high-quality epidemiological studies that can be traced back to the pioneering work of John Snow. 11 These include numerous confidential enquiries into perioperative and maternal deaths, where a mixed methods approach has combined quantitative epidemiological data with qualitative synthesis. Some will describe this work as clinical audit or service evaluation whereas others would consider it to be scientific study. Experienced biomedical researchers are familiar with the many reporting guidelines now covering almost every type of scientific research. But should such guidelines be applied to projects such as NAP6? The EQUATOR network provides a wealth of information on reporting guidelines as part of a mission to promote accurate, complete, and transparent reporting of health research in order to promote both reproducibility and utility. 12 Of note, these include guidelines for quantitative and qualitative research. The importance of accurate and transparent scientific reporting is such that all children are taught this skill in school. Some journals will immediately reject submissions that fail to apply the relevant guideline in full, whereas others, including the BJA, are less strict. It is reasonable to discuss whether these principles should be applied more widely to all reports published in scientific journals. It is clear that complex mixed-methods studies are difficult to fit into the template of a reporting guideline. This is especially true for large projects with multiple outputs. High impact clinical audits such as the UK National Confidential Enquiries into Perioperative Deaths (NCEPOD) and NAPs have for many years been reported in a structured but subjective way with clinical experts highlighting areas of importance and describing lessons for future practice. These projects were led by clinical experts and not by biomedical or clinician scientists, and driven by clinical need rather than scientific curiosity. In many respects these previous projects had more in common with a public enquiry than scientific study. These concerns have been highlighted in a formal review of the National Audit Projects published in 2013, 13 and have been a topic of considerable discussion during the peer review process for the components of NAP6 reported in the BJA.
The clearest example of how NAP6 moves away from the philosophy of standardised reporting is in its formulation of guidelines and recommendations. The final NAP6 paper in this issue includes two appendices. 8 The first appendix describes clinical guidelines for the care of patients who have previously experienced a suspected episode of perioperative anaphylaxis and require surgical intervention before it is feasible to undertake investigations to confirm anaphylaxis and determine the allergen. These guidelines may have been improved by the use of a formal consensus methodology, such as the Rand/University of CaliforniaeLos Angeles (UCLA) appropriateness method. 14 The second appendix contains almost 90 recommendations for anaesthetists arising from NAP6. Although these appendices were included in the peer review of the article, the NAP6 authors felt unable to consider any but the most minor changes because it was not feasible to reconvene the multi-disciplinary panel that had formulated them. Had these guidelines been developed using a consensus methodology and reported according to a standardised guideline, the recommendations would have been treated as a scientific output and would not have required any debate in the peer review process. Perhaps the most prominent approach to the development and reporting of clinical recommendations is that of the GRADE Working Group. 15 The UK National Institute for Health and Clinical Excellence (NICE) takes a similar approach. 16 One of the key elements of both the GRADE and NICE approaches is the requirement for a clear description of the evidence that informs each recommendation. This approach would need some adaptation for the NAPs because the recommendations are based on the evidence collected in addition to previously published works. The NAP6 recommendations will be supported by the majority of those with expertise in perioperative anaphylaxis, but there are several examples of how they might be improved, or their impact enhanced, with a more standardised approach:
1. There should be an indication of the strength of a recommendation, such as the GRADE system, or simply through standardised adjectives as used by NICE. The usefulness of this requirement is illustrated by NAP6 recommendation 24, which advises the administration of corticosteroids as part of resuscitation of perioperative anaphylaxis. Few would dispute the wisdom of this guidance, but the reader needs to be aware that the clinical evidence underpinning this is very weak. This would allow an interpretation where a patient may have a greater than usual risk of harm from the treatment. 2. There should be clear methodology for how consensus was achieved and disagreements handled and reported. This would help the reader to make informed decisions about how to implement the recommendations in their clinical service, and the urgency of doing so. 3. The intended impact of each recommendation should be clearly articulated. The first NAP6 recommendation is that the detection and management of perioperative anaphylaxis should be included in the training curriculum for anaesthetists and intensivists. As this has been the case for some time, it is unclear what needs to change. What evidence was identified in NAP6 that could inform better training for healthcare practitioners in the perioperative team? 4. A list of recommendations should be prioritised for implementation. There is a risk with such an extensive list of recommendations that only those that are cheap or simple may be implemented. Alternatively, sceptics may argue that the prospect of tackling so many recommendations is impractical and that the entire guideline should be dismissed.
Conclusions
All members of the NAP6 team must be congratulated for their work to shed light on a complex clinical problem of great concern to healthcare practitioners and patients alike. The information they provide will undoubtedly save lives worldwide by further improving standards of patient care. However, the question lingers as to whether this global impact might have been greater still if now well-established standards of guideline development and scientific reporting were applied from the outset of this work.
Authors' contributions
RP and PH contributed equally to this article.
Declaration of interest
RP holds research grants, and has given lectures and/or performed consultancy work for Nestle Health Sciences, BBraun, Medtronic, Glaxo Smithkline, Intersurgical, and Edwards Lifesciences, and is a member of the associate editorial board of the British Journal of Anaesthesia. PMH is a member of the editorial board of the British Journal of Anaesthesia.
Perioperative anaphylaxis usually presents unexpectedly and, in many cases, with dramatic symptoms requiring prompt recognition and action to ensure the optimal outcome for the patient. Because of the rare occurrence of these events it is difficult for individual anaesthetists to build up experience in treating these reactions. A paper from the 6th National Audit Project (NAP6), which was a survey of anaesthetists' experiences with perioperative anaphylaxis, showed that on average an anaesthetist experiences a case of perioperative anaphylaxis once every 7.25 yr. 1 This issue of the British Journal of Anaesthesia, includes five additional reports from NAP6.
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The many projects and studies implemented during NAP6 might be of direct benefit to patients by increasing awareness about perioperative anaphylaxis among anaesthetists, allergists, and immunologists. The multidisciplinary working group behind NAP6 addressed many different clinical problems, and the resulting data include a combination of novel findings and confirmation of previous findings regarding the management and outcomes of perioperative anaphylaxis. The focus of this editorial will be on the management and outcomes of perioperative anaphylaxis included in the paper by Harper and colleagues. 6 The quality of the immediate management of cases of suspected perioperative anaphylaxis was evaluated by a multidisciplinary review panel including anaesthetists, intensivists, allergists, immunologists, and patient representatives. 3 Recognition of anaphylaxis was judged as prompt in an impressive 97% of cases and treatment with epinephrine was prompt, defined as within 10 min, in 83% of cases. However, overall quality of management was judged as 'good' in just 46% of cases, 'good and poor' in 39% of cases, and 'poor' in only 15% of cases. During the review process, management was judged as inadequate in cases where systolic arterial pressure was <50 mm Hg and cardiac compressions were not initiated. This probably contributed significantly to the surprisingly low rate of cases where management was judged as 'good' (46%). This definition has never been used in previous guidelines on perioperative anaphylaxis and, as data on the duration of profound hypotension are not available, in some cases it might be based on a single measurement. In such cases, it could be detrimental to the patient if initiation of cardiac compressions distracts from immediate administration of epinephrine and fluids, the immediate goals in management of anaphylaxis. Anaphylaxis management guidelines were immediately accessible in 86% of cases and, in 60% of cases, Association of Anaesthetists of Great Britain and Ireland (AAGBI) guidelines were followed. 7 This underlines the fact that perioperative anaphylaxis is a rare event, and that the availability of guidelines with clear recommendations of management is important. Pivotal to the treatment of anaphylaxis is prompt administration of epinephrine with correct dosing. For non-fatal cases, the multidisciplinary panel in NAP6 judged that epinephrine was not administered when indicated in 19% of cases; in 11%, epinephrine was not given at all and in 8.4%, it was given late. Thus, a significant proportion of patients did not receive correct treatment with epinephrine. Only a few studies have provided details on treatment with epinephrine, and the NAP6 findings confirm previous observations on epinephrine dosage and administration route. 8, 9 A total of 82% DOI of original article: doi: 10.1016/j.bja.2018.04.015.
